Correction to: Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan
Crossref DOI link: https://doi.org/10.1007/s10157-019-01694-w
Published Online: 2019-01-23
Published Print: 2019-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tanaka, Tetsuhiro
Nangaku, Masaomi
Imai, Enyu
Tsubakihara, Yoshiharu
Kamai, Masatoshi
Wada, Michihito
Asada, Shinji
Akizawa, Tadao
Text and Data Mining valid from 2019-01-23
Article History
First Online: 23 January 2019